The 25th Annual MAD-ID Meeting, The Antimicrobial Stewardship Meeting® will take place May 10-13, 2023, at the Hyatt Regency Orlando in Orlando, Florida.

Pharmacists, physicians, nurses and other healthcare providers will be given the opportunity to participate in this three-and-a-half-day educational program specifically designed to develop competency and help learners translate recent research and guidelines to patient care and antimicrobial stewardship while earning pharmacy (CPE) or medical (CME) continuing education credit.

 

Wednesday, May 10, 2023
12:00 pm – 8:00 pm Registration Desk
1:00 pm – 3:30 pm Trainee Pre-Meeting Session: (not a CE accredited event)
TBD Title
Speaker(s): XX
Fellow(s): XX
3:30 pm – 4:00 pm Break
4:00 pm – 6:00 pm

AASP

Classrooms #1- 4
All Classrooms are one hour each then repeated, you may attend two of the four offered.
Classroom 1A Identifying and Addressing Health Disparities in Antimicrobial Use at Your Institution 

ACPE Program #:          XX (1.0 Contact Hour)
ACPE Activity Type:      XX

Moderator:     Susan Davis, PharmD
Facilitator:      Jacinda Abdul-Mutakabbir, PharmD, MPH

Learning Objectives:
Upon completion of this session, the participant will be able to:

  1. Describe the relationship between systemic racism, social determinants of health, and the treatment of patients with infections
  2. Identify factors in antimicrobial stewardship processes and policies that could result in disparities in care
  3. (Application based activity) Develop a strategy to evaluate and reduce health disparities in antimicrobial use in individual practice settings
Classroom 1B   Beta-lactam TDM, Practical Protocols to Make it Work

ACPE Program #:          XX (1.0 Contact Hour)
ACPE Activity Type:      XX

Moderator:      Mike Rybak, PharmD, MPH, PhD
Facilitator(s):   Kate DeSear, PharmD and Veena Venugopalan, PharmD

Learning Objectives:
Upon completion of this session, the participant will be able to:

  1. Identify patients who may benefit from BL TDM
  2. List potential barriers and opportunities for implementation of a BL TDM service
  3. Develop a workflow for beta-lactam TDM
Classroom 1C Implementing Stewardship in Community Hospital Settings

ACPE Program #:          XX (1.0 Contact Hour)
ACPE Activity Type:      XX

Moderator:      David Ha, PharmD
Facilitator:       Mary Hutton, PharmD

Learning Objectives:
Upon completion of this session, the participant will be able to:

  1. Outline the unique and diverse challenges faced by antibiotic stewards in community hospital settings
  2. Discuss approaches to launch or expand an antibiotic stewardship program in a community hospital
  3. Identify practical strategies to apply in your practice setting
Classroom 1D Precepting and Teaching the ID Learner: Insights from the ID Educators Network
ACPE Program #:          XX (1.0 Contact Hour)
ACPE Activity Type:      XXModerator:       Kerry LaPlante, PharmD
Facilitator:        Meghan Jeffres, PharmDLearning Objectives:
Upon completion of this session, the participant will be able to:

  1. Discuss evidence-based educational techniques and their application to infectious diseases education
  2. Identify best practices for infectious diseases education in didactic and experiential settings
  3. (Application based activity) Apply best practices in creation of a chalk talk 
6:30 pm  – 8:00 pm Welcome Reception

 

Thursday, May 11, 2023
6:30 am – 6:30 pm Registration/Hospitality Desk
6:30 am – 8:00 am TBD Satellite Symposium
(TBD if CE Credit is available with supplementary registration, see Symposium flyer for detail)
7:00 am – 8:00 am Continental Breakfast in Exhibit Hall
8:00 am – 10:00 am
AASP
Classrooms #5-8
All Classrooms are 1 hour each and then repeated; you may attend two of the four offered
Classroom 2A              Building the Right Stewardship Model for Your ICU

ACPE Program #:          XX (1.0 Contact Hour)
ACPE Activity Type:      XX

Moderator:       Kerry LaPlante, PharmD
Facilitator:        Rebekah Moehring, MD, MPH

Learning Objectives:
Upon completion of this session, the participant will be able to:

  1. Describe behavioral and social factors impacting stewardship collaboration in ICUs
  2. Identify high priorities for antibiotic optimization in ICU settings
  3. (Application based activity) Design a plan for improving antimicrobial stewardship in an intensive care setting
Classroom 2B              Simple Strategies to Improve Outpatient Antimicrobial Use
ACPE Program #:          XX (1.0 Contact Hour)
ACPE Activity Type:      XXModerator:      Susan Davis, PharmD
Facilitator:       Mike Klepser, PharmD

Learning Objectives:
Upon completion of this session, the participant will be able to:

  1. Explain factors contributing to inappropriate antibiotic use in outpatient settings
  2. Identify resources to promote safe antimicrobial use in routine outpatient practice
  3. Demonstrate strategies to engage patients, caregivers, or prescribers about safe antibiotic use
Classroom 2C              Implementing Guidance in the Treatment of Gram-negative Infections
ACPE Program #:          XX (1.0 Contact Hour)
ACPE Activity Type:      XXModerator:       Mike Rybak, PharmD, MPH, PhD
Facilitator:        Sam Aitken, PharmD, MPH

Learning Objectives:
Upon completion of this session, the participant will be able to

  1. List potential barriers to implementing GN treatment guidance
  2. Identify resources-collaborators for successful implementation of GN guidance
  3. Describe methods for documenting outcomes post implementation of GN guidance 
Classroom 2D  Diagnostic Stewardship Process and Practice
ACPE Program #:          XX (1.0 Contact Hour)
ACPE Activity Type:      XXModerator:       David Ha, PharmD
Facilitator:        Anthony Casapao, PharmD, MPH

Learning Objectives:
Upon completion of this session, the participant will be able to:

  1. Define diagnostic stewardship and how it is interconnected with antibiotic stewardship
  2. Outline strategies for antibiotic stewardship programs to collaborate with clinical laboratories on diagnostic stewardship efforts
  3. Describe how to demonstrate impact of diagnostic stewardship interventions 
10:00 am – 10:30 am Break in Exhibit Hall
10:30 am – 10:45 am Welcome and Opening Remarks
Moderator: Mike Rybak, PharmD, MPH, PhD 
10:45 am – 11:45 am

 

Keynote: Antimicrobial Stewardship; Past, Present, and Future

ACPE Program #:          XX (1.0 Contact Hour)
ACPE Activity Type:      XX

Moderator:       Kerry LaPlante, PharmD
Speaker:          Lauri Hicks, DO

Learning Objectives:
Upon completion of this session, the participant will be able to:

  1. Discuss clinical, social, and regulatory factors impacting future antibiotic use and resistance trends
  2. Forecast emerging antimicrobial stewardship priorities in health equity, and strategies for institutional and community settings
  3. Describe a framework for combatting emerging antimicrobial resistance threats in the future
11:45 am – 1:30 pm            Lunch on own
11:45 am – 1:30 pm Melinta Therapeutics Satellite Symposium
(TBD if CE Credit is available with supplementary registration, see Symposium flyer for detail)
1:30 pm – 3:00 pm

AASP

 

 

De-escalation

ACPE Program #:          XX (1.5 Contact Hours)
ACPE Activity Type:      XX

Moderator:      Susan Davis, PharmD

Plenary 1A      Oral Antibiotics as Stepdown for Serious Infections Speaker:           Erin McCreary, PharmD

Plenary 1B       Advances in De-escalation
Speaker:           Rebekah Moehring, MD, MPH

Learning Objectives:
Upon completion of this session, the participant will be able to:

  1. Define de-escalation in terms of spectrum, route, and duration of therapy
  2. Describe the evidence to support oral antibiotics as stepdown therapy for serious infections including bacteremia and bone and joint infection
  3. Explain successful approaches to optimize duration of antimicrobial therapy
3:00 pm – 3:30 pm Break in Exhibit Hall
3:30 pm – 5:00 pm

AASP

Innovations in ID

ACPE Program #:          XX (1.5 Contact Hours)
ACPE Activity Type:      XX

Moderator:       Mike Rybak, PharmD, MPH, PhD

Plenary 2A       New Antibiotic Development
Speaker:           George Sakoulas, MD

Plenary 2B       Advances in Immunomodulatory Therapies
Speaker:           Dave Feola, PharmD, PhD

Learning Objectives:
Upon completion of this session, the participant will be able to:

  1. Describe the gaps in antibiotic and immunomodulatory therapy development
  2. List and describe the novel antibiotic and immunomodulatory therapies
  3. Identify the potential patients who would benefit from novel antibiotic and immunomodulatory therapy
5:00 pm – 6:30 pm Scientific Poster Session and Cocktail Reception in Exhibit Hall
(not accredited) 

 

Friday, May 12, 2023
6:30 am – 5:00 pm Hospitality Desk
6:30 am – 8:00 am TBD Satellite Symposium
(TBD if CE Credit is available with supplementary registration, see Symposium flyer for detail)
7:00 am – 8:00 am            Continental Breakfast in Exhibit Hall
8:00 am – 9:30 am

AASP

Bugs & Drugs
ACPE Program #:          XX (1.5 Contact Hours)
ACPE Activity Type:      XXModerator:       Mike Rybak, PharmD, MPH, PhD

Plenary 3A      What’s Hot in Bugs & Drugs:  Update on Treatment of Non-fermenters
Speaker:          Sam Aitken, PharmD, MPH

Plenary 3B      Expert Opinion:  Evaluating Therapeutic Gaps in the Guidelines/
Making Recommendations When the Evidence is Gray

Speaker:           Meghan Jeffres, PharmD

Learning Objectives:
Upon completion of this session, the participant will be able to:

  1. List the problematic non-fermenter GN pathogens
  2. Describe the latest recommendations for the treatment of GN non-fermenters
  3. Identify the therapeutic gaps in guidelines associated with treatment of Staphylococcus aureus infection, focus on bone and vascular infections
  4. Fill the guideline gaps about the treatment of Staphylococcus aureus infections with primary literature
9:30 – 10:00 am Break in Exhibit Hall
10:00 – 11:30 am

AASP

 

A Clinician’s Guide to MICs and Breakpoints

ACPE Program #:          XX (1.5 Contact Hours)
ACPE Activity Type:      XX

Moderator:      David Ha, PharmD

Plenary 4A     MIC, ECOFFs, and Breakpoints; What do I Need to Know as a Clinician?
Speaker:         Kerry LaPlante, PharmD
Plenary 4B     Different Organizations, Different Breakpoints:  Making Sense of Recent Updates to Susceptibility Breakpoints from CLSI, EUCAST, and USCAST
Speaker:          Jason Pogue, PharmD

Learning Objectives:
Upon completion of this session, the participant will be able to:

  1. Discuss the history, development, and utility of Antimicrobial Susceptibility Testing methodologies
  2. Evaluate practical applications and impact of breakpoints and MICs in common clinical scenarios
  3. Describe the approaches used to develop susceptibility interpretive criteria in different agencies (e.g. CLSI, FDA, USCAST, EUCAST)
11:30 am – 1:30 pm Lunch on own
11:45 am – 1:30 pm TBD Satellite Symposium
(TBD if CE Credit is available with supplementary registration, see Symposium flyer for detail)
1:30 pm – 3:00pm

AASP

Future of Diagnostics

ACPE Program #:          XX (1.5 Contact Hours)
ACPE Activity Type:      XX

Moderator:       Susan Davis, PharmD

Plenary 5A       Next Generation Technologies in ID Diagnostics
Speaker:           Jose Alexander, MD, D(ABMM), SM, MB(ASCP)

Plenary 5B       Point of Care Testing in Outpatient Care
Speaker:           Mike Klepser, PharmD

Learning Objectives:
Upon completion of this session, the participant will be able to:

  1. Identify emerging technologies for rapid microbial identification and susceptibility testing in inpatient and outpatient settings
  2. Describe the impact of new diagnostic technologies on antimicrobial use, patient outcome, and access to care
  3. Explain collaborative approaches for implementation of point of care testing in outpatient settings
3:00 pm – 3:30 pm Break in Exhibit Hall
3:30 pm – 5:00 pm

AASP

Building the Team
ACPE Program #:          XX (1.5 Contact Hours)
ACPE Activity Type:      XXModerator:       David Ha, PharmD

Plenary 6A      The Team: Collaborating with Internal Medicine and Other Teams to Improve Antibiotic Use
Speaker:           Valerie Vaughn, MD, MS

Plenary 6B       Bringing People Together Across the Team:  Patient Advocate,
Patient Experiences

Speakers:         Christian Lillis

Learning Objectives:
Upon completion of this session, the participant will be able to:

  1. Describe the importance of collaboration between antibiotic stewardship programs and internal medicine and other clinicians
  2. Identify practical strategies for antibiotic stewardship programs to collaborate with internal medicine and other clinicians
  3. Describe the patient perspective on consequences of antibiotic misuse and the importance antibiotic stewardship
5:00 pm – 6:00 pm Exhibitor Reception in Exhibit Hall

                       

Saturday, May 13, 2023
6:30 am – 1:00 pm Hospitality Desk
6:30 am – 8:00 am TBD Satellite Symposium
(TBD if CE Credit is available with supplementary registration, see Symposium flyer for detail)
7:00 am – 8:00 am Continental Breakfast in Foyer
8:00 am – 9:30 am

AASP

 

 

Prevention Matters (SHEA)

ACPE Program #:          XX (1.5 Contact Hours)
ACPE Activity Type:      XX

Moderator:      David Ha, PharmD

Plenary 7A      Immunization Stewardship
Speaker:          Michael Hogue, PharmD

Plenary 7B      Microbiome Stewardship and Live Biological Products Role in Prevention of Infectious Diseases
Speaker:           Sahil Khanna, MBBS,MS

Learning Objectives:
Upon completion of this session, the participant will be able to:

  1. Outline recent updates to CDC ACIP vaccine recommendations and their supporting clinical evidence
  2. Discuss the importance of the microbiome and fecal microbiota transplantation in prevention of infectious diseases
  3. Describe the role of live biological products in the prevention of Clostridioides difficile infection
9:30 am – 10:00 am Break in Foyer
10:00 am – 11:30 am

 

Therapeutics
ACPE Program #:          XX (1.5 Contact Hours)
ACPE Activity Type:      XXModerator:       Kerry LaPlante, PharmD

Plenary 8A/8B  Hot Topics: What Did You Miss in Infectious Diseases 2022-2023
Speaker(s): Jason Pogue, PharmD and Erin McCreary, PharmD

Learning Objectives:
Upon completion of this session, the participant will be able to:

  1. Identify major developments published in the ID literature from May 2022 thru March 2023
  2. Summarize important, new clinical studies or guidelines impacting antimicrobial use
  3. Discuss preliminary findings of key unpublished studies that were presented at recent ID conferences
11:30 am – 12:30 pm           

 

 

Meet the Professors
ACPE Program #:          XX (1.0 Contact Hour)
ACPE Activity Type:      XXFacilitator:        Mike Rybak, PharmD
Panelists:          TBD

Learning Objectives:
Upon completion of this session, the participant will be able to:

  1. List the top 5 antimicrobial therapy controversies of 2023
  2. Identify a therapeutic intervention associated with multidrug resistant pathogens
  3. Describe an antimicrobial stewardship issue that directly relates to your specific practice/institution
12:30 pm Meeting Adjourns